You have 9 free searches left this month | for more free features.

SB1518

Showing 1 - 25 of 30

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer Trial in Milwaukee (Pacritinib)

Recruiting
  • Prostate Cancer
  • Milwaukee, Wisconsin
    Froedtert & the Medical College of Wisconsin
Jul 18, 2022

COVID19, COVID-19, COVID Trial in United States (Pacritinib, Placebo)

Terminated
  • COVID19
  • +2 more
  • Orange, California
  • +20 more
Sep 23, 2021

Recurrent Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Therapy-Related Acute Myeloid Leukemia Trial in

Completed
  • Recurrent Adult Acute Myeloid Leukemia
  • +3 more
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Jan 23, 2019

Acute Myeloid Leukemia (AML) Trial in New York (Pacritinib, Decitabine, Cytarabine)

Terminated
  • Acute Myeloid Leukemia (AML)
  • New York, New York
    Weill Cornell Medical College
Jun 13, 2018

NSCLC, Nonsmall Cell Lung Cancer, NSCLC Trial in Saint Louis (Pacritinib, Erlotinib)

Terminated
  • Non-Small Cell Lung Cancer
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Feb 23, 2018

Colorectal Cancer Trial in Saint Louis (Pacritinib)

Terminated
  • Colorectal Cancer
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 27, 2017

Leukemia Trial in Houston (SB1518)

Terminated
  • Leukemia
  • SB1518
  • Houston, Texas
    UT MD Anderson Cancer Center
Jun 14, 2016

Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

Terminated
  • Primary Myelofibrosis
  • +2 more
  • Scottsdale, Arizona
  • +80 more
Sep 25, 2020

Amlodipine Verses S Amlodipine in Essential Hypertension

Recruiting
  • Essential Hypertension
  • S-amlodipine 2.5mg
  • Amlodipine 5mg
  • Seoul, Korea, Republic of
    Korea University Guro Hospital
Nov 10, 2020

Multiple Sclerosis, Anxiety, Depression Trial in Edmonton (Intensive Use of Patient Reported Outcome Measures and Open PROM

Recruiting
  • Multiple Sclerosis
  • +3 more
  • Intensive Use of Patient Reported Outcome Measures and Open PROM Availability to Treating Neurologist
  • Conservative Use of Patient Reported Outcome Measures and Blinded PROM Availability to Treating Neurologist
  • Edmonton, Alberta, Canada
    University of Alberta
Apr 6, 2022

Colorectal Adenocarcinoma, Mucinous Adenocarcinoma, Signet Ring Cell Adenocarcinoma Trial in Trondheim, Lørenskog, Oslo

Not yet recruiting
  • Colorectal Adenocarcinoma
  • +2 more
  • Trondheim, Trondelag, Norway
  • +2 more
Aug 15, 2022

Quality and Quantity of M-PRP Cellular Content Filgrastim vs.

Recruiting
  • Healthy
  • Gulf Breeze, Florida
    Andrews Research and Education Foundation
Oct 6, 2022

MDR-TB Trial in Worldwide (Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline), Moxifloxacin, Clofazimine)

Active, not recruiting
  • MDR-TB
  • Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline)
  • +9 more
  • Addis Ababa, Ethiopia
  • +12 more
Sep 27, 2021

Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

Terminated
  • Primary Myelofibrosis
  • +2 more
  • Scottsdale, Arizona
  • +121 more
Oct 21, 2021

Prostatic Tumors Trial in Taoyuan (Multimedia-Based Hormone Therapy Information Program)

Completed
  • Prostatic Neoplasms
  • Multimedia-Based Hormone Therapy Information Program
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital at Linkou
Mar 3, 2021

Healthy Trial in Saint-Petersburg (Combination Caplet with Loperamide HCl and Simethicone, Loperamide HCl, Simethicone)

Completed
  • Healthy
  • Combination Caplet with Loperamide HCl and Simethicone
  • +2 more
  • Saint-Petersburg, Russian Federation
    "Scientific and Research centre Eco-safety" Limited Liability Co
Sep 8, 2020

Modifications of Immune Microenvironment Induced by Neoadjuvant

Unknown status
  • Triple Negative Breast Cancer
  • biomarker evolution
  • (no location specified)
Apr 27, 2020

Crohn Disease, Genetic Predisposition, IBD Trial in Roanoke (Capsule endoscopy)

Recruiting
  • Crohn Disease
  • +2 more
  • Capsule endoscopy
  • Roanoke, Virginia
    Carilion Clinic
Apr 27, 2021

Intestinal Permeability, Nutritional Status and Quality of Life

Completed
  • Celiac Disease
  • +2 more
  • Blood draw once a time
  • Istanbul, Maltepe, Turkey
    Marmara University Institute of Health Sciences
Apr 17, 2020

Phenotyping Circulating and Lung Resident Eosinophils in Severe

Not yet recruiting
  • Severe Asthma
    • London, United Kingdom
      Royal Brompton & Harefield NHS Trust,
    Jul 6, 2020

    Multiple Sclerosis, Nurse's Role Trial in Edmonton (Nurse Practitioner (NP) Led Care Arm)

    Completed
    • Multiple Sclerosis
    • Nurse's Role
    • Nurse Practitioner (NP) Led Care Arm
    • Edmonton, Alberta, Canada
      University of Alberta
    Jun 26, 2020

    Anaemia Trial in Worldwide (Daprodustat, Darbepoetin alfa, Placebo)

    Completed
    • Anaemia
    • Andalusia, Alabama
    • +576 more
    Apr 12, 2022

    Sleep Apnea, Obstructive, Obesity Trial in St. Louis (Propofol Alone, Propofol+Benzo/Opioids)

    Terminated
    • Sleep Apnea, Obstructive
    • Obesity
    • St. Louis, Missouri
      Washington University School of Medicine
    Sep 8, 2016

    Hypothyroidism, Hyperthyroidism, Obesity Trial in Maastricht (Levothyroxine therapy (137.75 ± 23.75 µg/day))

    Completed
    • Hypothyroidism
    • +2 more
    • Levothyroxine therapy (137.75 ± 23.75 μg/day)
    • Maastricht, Limburg, Netherlands
      Maastricht UMC
    Jul 20, 2015

    Cancer Thrombosis Trial in Burlington (Supervised aerobic exercise training)

    Completed
    • Cancer Thrombosis
    • Supervised aerobic exercise training
    • Burlington, Vermont
      Fletcher Allen Healthcare
    Dec 3, 2014